Skip to main content
Clinical Trials/DRKS00025154
DRKS00025154
Completed
未知

Exposure therapy in virtual reality addressing public speaking anxiety in order increase willingness for in vivo exposure in patients with anxiety disorder and obsessive-compulsive disorder - Expo-VR-Wil

niversitätsklinikum Hamburg-Eppendorf0 sites90 target enrollmentApril 26, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
F42
Sponsor
niversitätsklinikum Hamburg-Eppendorf
Enrollment
90
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 26, 2021
End Date
December 5, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • Obsessive\-Compulsive Disorder and/or anxiety disorder (MINI criteria)
  • Gender: male, female
  • Minimum Age: 18 Years
  • Maximum Age: 75 Years
  • Consent to participate in a single VR\-session and the diagnostic interviews
  • Ability to give consent
  • Sufficient understanding of the German language

Exclusion Criteria

  • Psychotic symptoms (current or lifetime)
  • Severe neuropsychological disease
  • Current substance dependence
  • Physical illnesses that are a contraindication to exposures (e.g. heart disease)

Outcomes

Primary Outcomes

Not specified

Similar Trials